Single Use Support Opens US Office

Single Use Support, a leading process solution provider specializing in cold chain logistics, announces the opening of its latest branch office in Lexington, Massachusetts. Strategically positioned within proximity to the innovative pharmaceutical hub ofBoston, the new office underscores Single Use Support's ambition for further expansion and for improving efficiency and product quality in biopharmaceutical manufacturing.

The Lexington office, spanning 2,320 square feet, showcases Single Use Support's commitment to enhancing customer service and industry collaboration. CEO Christian Praxmarer emphasized the significance of the inauguration, stating, "Our increased presence in the USA reflects our dedication to advancing biopharmaceutical innovation. Andwith the opening of our showroom and the bolstered staffing in Lexington we will facilitate faster service for our customers."

Elevated Workforce to Strengthen Customer Service

In conjunction with the office opening, Single Use Support has expanded its US-based sales and service team with the addition of order management and automation experts. Both existing and prospective customers will greatly benefit fromthe increased presence of the pioneering process solutions provider in the US.

Several US-based pharmaceutical manufacturers and CDMOs have recently placed orders for consumables and platform systems for aliquoting, freeze/thaw, storage, and shipping of high-value drug substances. This is in line with Single UseSupport's 70% increase in non-COVID-related revenue by 2023 and a corresponding 40% increase in headcount over the last six months.

Expanded Demo Units in the US

As in Lexington, Single Use Support's platform and consumable solutions are already on display in Houston, Texas. The process solution provider's fluid and cold chain management units are part of the mRNA vaccine manufacturing programexecuted in collaboration with the National Center for Therapeutics Manufacturing and the Texas A&M University, demonstrating the crucial role of the company's fluid and cold chain management solutions in advancing cutting-edge biopharmaceutical technologies.

Markus Fürniß, Senior Director, Sales USA & Canada (l.), Bernhard Schlichtner, Chief Commercial Officer (m.), Christian Praxmarer, Chief Executive Officer (r.) cutting the ribbon.